DK151884C - Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number: DK151884C
Authority: DK; Denmark
Prior art keywords: imidazolylalkyl; incidental; analogue; preparation; acid addition
Prior art date: 1979-03-07

Application number

DK042580A

Other languages

Danish (da)

English (en)

Other versions

DK151884B (da

DK42580A (da

Inventor

Peter Edward Cross

Roger Peter Dickinson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-01-31

Publication date

1988-06-13

1980-01-31 Application filed by Pfizer filed Critical Pfizer

1980-09-08 Publication of DK42580A publication Critical patent/DK42580A/da

1988-01-11 Publication of DK151884B publication Critical patent/DK151884B/da

1988-06-13 Application granted granted Critical

1988-06-13 Publication of DK151884C publication Critical patent/DK151884C/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK042580A 1979-03-07 1980-01-31 Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf DK151884C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07
GB7908123		1979-03-07

Publications (3)

Publication Number	Publication Date
DK42580A DK42580A (da)	1980-09-08
DK151884B DK151884B (da)	1988-01-11
DK151884C true DK151884C (da)	1988-06-13

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK042580A DK151884C (da)	1979-03-07	1980-01-31	Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (36)

Country	Link
US (1)	US4273782A (ru)
JP (1)	JPS55133380A (ru)
KR (1)	KR850000760B1 (ru)
AR (1)	AR227015A1 (ru)
AT (1)	AT375366B (ru)
AU (1)	AU516957B2 (ru)
BE (1)	BE882113A (ru)
CA (1)	CA1120479A (ru)
CH (1)	CH649546A5 (ru)
CS (1)	CS253702B2 (ru)
DD (1)	DD149525A5 (ru)
DE (1)	DE3008632A1 (ru)
DK (1)	DK151884C (ru)
ES (2)	ES489220A0 (ru)
FI (1)	FI66860C (ru)
FR (1)	FR2450832A1 (ru)
GR (1)	GR67237B (ru)
HK (1)	HK89884A (ru)
HU (1)	HU184727B (ru)
IE (1)	IE49542B1 (ru)
IL (1)	IL59524A (ru)
IT (1)	IT1218420B (ru)
KE (1)	KE3467A (ru)
LU (1)	LU82224A1 (ru)
MY (1)	MY8500285A (ru)
NL (1)	NL182959C (ru)
NO (1)	NO152217C (ru)
NZ (1)	NZ193052A (ru)
PH (1)	PH15198A (ru)
PL (1)	PL128296B1 (ru)
PT (1)	PT70914A (ru)
SE (1)	SE440778B (ru)
SG (1)	SG67284G (ru)
SU (1)	SU1277894A3 (ru)
YU (1)	YU41911B (ru)
ZA (1)	ZA801328B (ru)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	인돌 유도체의 제조방법
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
AT376436B (de) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
EP0239306B1 (en)	1986-03-27	1993-06-02	Merck Frosst Canada Inc.	Tetrahydrocarbazole esters
JPH0832679B2 (ja) *	1986-09-05	1996-03-29	理化学研究所	Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
EP0427860A1 (en) *	1989-03-31	1991-05-22	Kyoto Pharmaceutical Industries, Ltd.	New imidazole derivatives, production thereof, and uses thereof as medicines
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
IE913204A1 (en) *	1990-09-13	1992-02-25	Beecham Group Plc	Novel compounds
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
ZA929788B (en) *	1991-12-18	1993-06-22	Schering Corp	Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring.
CA2109931A1 (en) *	1992-03-27	1993-10-14	Hiroshi Matsui	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) *	1992-09-18	1994-04-28	三洋電機株式会社	床暖房用パネル
TR200002869T2 (tr) *	1998-03-31	2000-12-21	The Institute For Pharmaceutical Discovery,Inc.	İkame edilmiş indolealkonik asitler.
AU2003297727A1 (en) *	2002-12-10	2004-06-30	Wyeth	Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
GB0324763D0 (en) *	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
CN101142184A (zh) *	2004-10-12	2008-03-12	解码遗传Ehf公司	用于阻塞性动脉疾病的磺酰胺迫位取代的双环化合物
WO2007024944A1 (en) *	2005-08-25	2007-03-01	Schering Corporation	Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
RU2008149518A (ru) *	2006-05-16	2010-06-27	Декод Дженетикс, Ехф. (Is)	Способ получения 7-(акрилоил) индолов
NZ574375A (en)	2006-07-22	2011-06-30	Oxagen Ltd	2-(5-fluoro-2-methyI-3-(2-(phenylsulfonyl)benzyl)-1H-indol-1-yl) acetic acid derivatives having CRTH2 antagonist activity
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
EP2543368A1 (en)	2007-12-11	2013-01-09	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
DK2250161T3 (da)	2008-01-18	2014-01-27	Atopix Therapeutics Ltd	Forbindelser med CRTH2-antagonistaktivitet
US7750027B2 (en) *	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
US20100022613A1 (en) *	2008-01-22	2010-01-28	Oxagen Limited	Compounds Having CRTH2 Antagonist Activity
JP2011509991A (ja) *	2008-01-22	2011-03-31	オキサジェンリミテッド	Ｃｒｔｈ２アンタゴニスト活性を有する化合物
US8772495B2 (en) *	2008-05-23	2014-07-08	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein inhibitor
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
JP2014518223A (ja) *	2011-06-20	2014-07-28	アルツハイマーズ・インスティテュート・オブ・アメリカ・インコーポレイテッド	化合物とその治療用途
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
WO2019191410A1 (en) *	2018-03-29	2019-10-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (ru) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
DK376078A (da) *	1977-08-26	1979-02-27	Wellcome Found	Fremgangsmaade til fremstilling af amidazoler
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) *	1978-02-24	1981-08-05	Pfizer Limited	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/da active
- 1980-03-04 HU HU80498A patent/HU184727B/hu not_active IP Right Cessation
- 1980-03-04 CS CS801492A patent/CS253702B2/cs unknown
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 PL PL1980222470A patent/PL128296B1/pl unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-05 YU YU614/80A patent/YU41911B/xx unknown
- 1980-03-05 LU LU82224A patent/LU82224A1/fr unknown
- 1980-03-05 SE SE8001736A patent/SE440778B/sv not_active IP Right Cessation
- 1980-03-05 ES ES489220A patent/ES489220A0/es active Granted
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-05 IL IL59524A patent/IL59524A/xx unknown
- 1980-03-05 SU SU802891745A patent/SU1277894A3/ru active
- 1980-03-05 FI FI800672A patent/FI66860C/fi not_active IP Right Cessation
- 1980-03-06 AR AR280198A patent/AR227015A1/es active
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 NO NO800650A patent/NO152217C/no unknown
- 1980-03-06 CH CH1781/80A patent/CH649546A5/de not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/it active
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/ko active
- 1980-03-06 FR FR8005054A patent/FR2450832A1/fr active Granted
- 1980-03-06 DD DD80219495A patent/DD149525A5/de not_active IP Right Cessation
- 1980-03-06 PT PT70914A patent/PT70914A/pt not_active IP Right Cessation
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/xx not_active IP Right Cessation
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 JP JP2856380A patent/JPS55133380A/ja active Granted
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/de active Granted
- 1980-03-06 BE BE0/199699A patent/BE882113A/fr not_active IP Right Cessation
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/xx unknown
- 1980-03-06 AT AT0125780A patent/AT375366B/de not_active IP Right Cessation
- 1980-11-14 ES ES496889A patent/ES8205789A1/es not_active Expired
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/xx unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/xx unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/xx unknown

Also Published As

Publication number	Publication date
SU1277894A3 (ru)	1986-12-15
SG67284G (en)	1985-03-15
FR2450832B1 (ru)	1983-04-22
JPS6141513B2 (ru)	1986-09-16
FI66860C (fi)	1984-12-10
NZ193052A (en)	1984-07-06
PL128296B1 (en)	1984-01-31
CH649546A5 (de)	1985-05-31
BE882113A (fr)	1980-09-08
HU184727B (en)	1984-10-29
ATA125780A (de)	1983-12-15
AU516957B2 (en)	1981-07-02
NO800650L (no)	1980-09-08
JPS55133380A (en)	1980-10-17
LU82224A1 (fr)	1980-06-06
NL182959C (nl)	1988-06-16
PT70914A (en)	1980-04-01
DE3008632A1 (de)	1980-10-16
PH15198A (en)	1982-09-17
NO152217B (no)	1985-05-13
DK151884B (da)	1988-01-11
YU41911B (en)	1988-02-29
YU61480A (en)	1983-12-31
CA1120479A (en)	1982-03-23
AU5623180A (en)	1980-09-11
ES496889A0 (es)	1982-08-01
PL222470A1 (ru)	1980-12-01
FI800672A (fi)	1980-09-08
KE3467A (en)	1984-11-09
MY8500285A (en)	1985-12-31
AT375366B (de)	1984-07-25
AR227015A1 (es)	1982-09-15
DE3008632C2 (ru)	1988-02-25
ES8205789A1 (es)	1982-08-01
US4273782A (en)	1981-06-16
CS253702B2 (en)	1987-12-17
HK89884A (en)	1984-11-23
IE800453L (en)	1980-09-07
IT1218420B (it)	1990-04-19
ES8104278A1 (es)	1981-04-01
GR67237B (ru)	1981-06-25
IE49542B1 (en)	1985-10-30
NO152217C (no)	1985-08-21
IT8020399A0 (it)	1980-03-06
ZA801328B (en)	1981-03-25
KR850000760B1 (ko)	1985-05-25
SE8001736L (sv)	1980-09-08
FR2450832A1 (fr)	1980-10-03
SE440778B (sv)	1985-08-19
ES489220A0 (es)	1981-04-01
IL59524A0 (en)	1980-06-30
KR830001928A (ko)	1983-05-19
NL8001351A (nl)	1980-09-09
FI66860B (fi)	1984-08-31
DK42580A (da)	1980-09-08
IL59524A (en)	1982-11-30
DD149525A5 (de)	1981-07-15

Publication	Publication Date	Title
DK151884C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK151623C (da)	1988-07-18	Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK147362C (da)	1988-06-27	Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK151331C (da)	1988-04-25	Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK149308C (da)	1986-12-08	Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK162714C (da)	1992-04-21	Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf
DK149895C (da)	1987-04-21	Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK164545C (da)	1992-11-30	Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK149630C (da)	1987-01-26	Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf
DK151017C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK149569C (da)	1987-02-02	Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf
DK157862C (da)	1990-08-06	Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK154950C (da)	1989-05-29	Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK158658C (da)	1990-12-31	Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK142544C (da)	1981-08-17	Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK151805C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK149841C (da)	1987-04-21	Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK149077C (da)	1986-06-16	Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK146066C (da)	1983-11-14	Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf
DK152427C (da)	1988-07-25	Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK152208C (da)	1988-08-08	Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK165005C (da)	1993-02-08	Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK144793C (da)	1982-11-01	Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK157023C (da)	1990-03-19	Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK160874C (da)	1992-02-24	Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf